Amrutanjan Health Care Ltd-$
Amrutanjan Health Care Ltd-$ (AMRUTANJAN) last traded at ₹524, a market capitalisation of ₹1,515 crore, on a P/E of 24.4. Over the past 52 weeks the stock has ranged between ₹483 and ₹791. Amrutanjan Health Care Ltd-$ last reported results for the quarter ended Jun 2026, with sales of ₹103 crore and net profit of ₹4.37 crore. Figures are as of 25 Aug 2026 and are not real time.
Amrutanjan Health Care Ltd-$ share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Amrutanjan Health Care Ltd-$ quarterly results
In the quarter ended Jun 2026, sales were ₹103 cr, up 9.5% from ₹94.05 cr a year earlier. Net profit was ₹4.37 cr, down 47.4% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 110 | 123 | 135 | 94.05 | 118 | 141 | 150 | 103 |
| Expenses | 96.32 | 99.4 | 118 | 85.61 | 101 | 116 | 124 | 96.73 |
| Operating profit | 13.6 | 23.35 | 17.7 | 8.44 | 16.52 | 25.17 | 25.55 | 6.24 |
| OPM % | 12.37% | 19.02% | 13.07% | 8.97% | 14.04% | 17.85% | 17.06% | 6.06% |
| Other income | 4.05 | 4.36 | 4.82 | 4.43 | 4.3 | 2.87 | -2.88 | 1.78 |
| Interest | 0.06 | 0.06 | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 |
| Depreciation | 1.65 | 1.66 | 1.62 | 1.53 | 1.56 | 1.62 | 1.61 | 1.92 |
| Profit before tax | 15.94 | 25.99 | 20.86 | 11.29 | 19.21 | 26.37 | 21.01 | 6.06 |
| Tax % | 25.97% | 25.93% | 27.23% | 26.40% | 27.33% | 26.20% | 22.94% | 28.05% |
| Net profit | 11.8 | 19.25 | 15.18 | 8.31 | 13.96 | 19.45 | 16.19 | 4.37 |
| EPS (₹) | 4.08 | 6.66 | 5.25 | 2.87 | 4.83 | 6.73 | 5.60 | 1.51 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Amrutanjan Health Care Ltd-$ annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 333 | 406 | 380 | 421 | 452 | 503 | 511 |
| Operating profit | 75 | 80 | 45 | 52 | 58 | 76 | 73 |
| OPM % | 22% | 20% | 12% | 12% | 13% | 15% | 14% |
| Net profit | 61 | 67 | 40 | 45 | 51 | 58 | 54 |
| EPS (₹) | 20.93 | 22.99 | 13.63 | 15.55 | 17.58 | 20.03 | 18.67 |
TTM is the trailing twelve months to the most recent quarter.
Amrutanjan Health Care Ltd-$ growth and returns
- 10 Years
- 11%
- 5 Years
- 9%
- 3 Years
- 10%
- TTM
- 11%
- 10 Years
- 12%
- 5 Years
- 1%
- 3 Years
- 17%
- TTM
- 14%
- 10 Years
- 9%
- 5 Years
- -6%
- 3 Years
- -5%
- 1 Year
- -26%
- 10 Years
- 19%
- 5 Years
- 18%
- 3 Years
- 17%
- Last Year
- 19%
Amrutanjan Health Care Ltd-$ shareholding pattern
Promoters held 46.52% at Jun 2026, broadly unchanged since Jun 2025. FIIs 2.44% and DIIs 12.29%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 46.52% | 46.52% | 46.52% | 46.52% | 46.52% | 46.52% | 46.52% | 46.52% |
| FIIs | 2.34% | 2.30% | 2.30% | 2.41% | 2.38% | 2.27% | 2.17% | 2.44% |
| DIIs | 10.60% | 11.13% | 11.41% | 12.70% | 12.90% | 13.00% | 12.66% | 12.29% |
| Public | 40.50% | 40.01% | 39.75% | 38.34% | 38.16% | 38.18% | 38.61% | 38.72% |
| No. of shareholders | 54,536 | 53,856 | 51,674 | 49,431 | 47,954 | 46,675 | 45,805 | 45,135 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Amrutanjan Health Care Ltd-$ corporate filings
- Investor Presentation for the Quarter Ended 30th June 2026Company Updatemedium impact
Cruxal's analysis: Amrutanjan Health Care Limited reported Q1 FY27 net sales of 102.97 crore, a 9.48% growth…
Read the full analysis - Record Date for the Final Dividend and AGMCorp. Actionlow impact
Cruxal's analysis: Amrutanjan Health Care Limited has officially announced September 11, 2026, as the record…
Read the full analysis - Financial Results and Outcome of the Board MeetingBoard Meetingmedium impact
Cruxal's analysis: Amrutanjan Health Care reported Q1 FY27 revenue of 102.97 crore, reflecting a 9.5% YoY…
Read the full analysis - Additional Details Required for Corporate Announcement filed under Regulation 30 of SEBI (LODR) Regulations, 2015Company Updatelow impact
Cruxal's analysis: The stock exchange has requested additional information regarding a previous corporate…
Read the full analysis - Amrutanjan Health Care Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve the Unaudited Financial ....Board Meetinglow impact
Cruxal's analysis: Amrutanjan Health Care Limited has formally intimated the stock exchanges regarding a…
Read the full analysis - Commissioning of New Manufacturing FacilityCompany Updatemedium impact
Cruxal's analysis: Amrutanjan Health Care has officially commissioned a new manufacturing facility as of…
Read the full analysis - Announcement under Regulation 30 (LODR)- Credit RatingCompany Updatelow impact
Cruxal's analysis: Amrutanjan Health Care Limited has been assigned an 'CARE A; Stable' issuer rating by…
Read the full analysis - The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for DSP Trustee Pvt Ltd & OthersInsider Trading / SASTlow impact
Cruxal's analysis: Amrutanjan Health Care Limited has witnessed a reduction in shareholding by DSP Mutual…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Amrutanjan Health Care Ltd-$
Cruxal reads every Amrutanjan Health Care Ltd-$ filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.